Haplotyping in patients with genetically proven Myotonic Dystrophy type 2
Completed
- Conditions
- Myotonic Dystrophy type 2Proximal Myotonic Myopathy (PROMM)10029299
- Registration Number
- NL-OMON43063
- Lead Sponsor
- Radboud Universitair Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 35
Inclusion Criteria
genetically proven DM2, minimum age: 18 years old
Exclusion Criteria
n.a.
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Will the genetic material in the 3q21.3 region be the same in all patients with<br /><br>DM2</p><br>
- Secondary Outcome Measures
Name Time Method <p>Do DM2 patients with an autoimmune disease have a different haplotype than that<br /><br>of DM2 patients without an autoimmune disease.</p><br>